As a social impact fund, 1P Impact Capital provides venture capital to private companies driving impact or solving a critical piece of the equation to address homelessness, education, gun safety, or climate change.
For more information, visit www.1P.org.
AllerFund is the first venture fund exclusively focused on commercializing innovations to support the food allergic community.
Food allergies have reached epidemic proportions in this country and around the world. While much philanthropic funding has gone into food allergy research, little investment capital has been available to commercialize concepts which will improve the lives of the food allergic community. AllerFund was created to change that equation. Formed as a for-profit, early-stage venture fund, AllerFund seeks to accelerate the development and commercialization of new treatments, diagnostics and products for children and adults with food allergies.
For more information, visit www.AllerFund.com.